“Zombie” Macrophages for Targeted Drug Delivery to Treat Acute Pneumonia

Authors:
Publisher website
Google Scholar
Abstract
A cell-based drug delivery system has emerged as a promising drug delivery platform. Due to their innate inflammatory tropism, natural and engineered macrophages have exhibited targeted accumulation in inflammatory tissues, which has allowed targeted delivery of medicine for the treatment of a variety of inflammatory diseases. Nevertheless, live macrophages may take up the medicine and metabolize it during preparation, storage, and in vivo delivery, sometimes causing unsatisfactory therapeutic efficacy. In addition, live macrophage-based drug delivery systems are usually freshly prepared and injected, due to the poor stability that does not allow storage. "Off-the-shelf" products would be indeed conducive to the timely therapy of acute diseases. Herein, a cryo-shocked macrophage-based drug delivery system was developed via supramolecular conjugation of cyclodextrin (CD)-modified "zombie" macrophages and adamantane (ADA)-functionalized nanomedicine. "Zombie" macrophages exhibited a much better storage stability over time than their counterpart live macrophage drug carriers and maintained cell morphology, membrane integrity, and biological functions. In an acute pneumonia mouse model, "zombie" macrophages carried quercetin-loaded nanomedicine, hand-in-hand, to the inflammatory lung tissues and effectively alleviated the inflammation in mice.
Funding Information
  • Universidade de Macau (MYRG2022-00081-ICMS, SHMDF-VSEP/2022/001)
  • Fundo para o Desenvolvimento das Ci??ncias e da Tecnologia (0065/2021/A2, 0086/2022/A2, SKL-QRCM(UM)-2023-2025)
  • National Natural Science Foundation of China (22071275, 22271323)
  • Shenzhen Science and Technology Innovation Commission (EF023/ICMS-WRB/2022/SZSTIC)

This publication has 42 references indexed in Scilit: